Rishi Gupta

Insider Reports History

Entity
Individual
Location
C/O Chemocentryx, Inc., 850 Maude Avenue, Mountain View, CA
Signature
/s/ Venkat Ramanan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rishi Gupta:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Enliven Therapeutics, Inc. Director, 10%+ Owner Common Stock 7.66M $170M $22.14 May 16, 2024 Indirect
Verona Pharma plc Director Ordinary Shares 3.78M $75.6M $20.00 May 15, 2023 Indirect
Turnstone Biologics Corp. Director, 10%+ Owner Common Stock 3.1M Jul 20, 2023 Indirect
Enliven Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 23.4K Feb 13, 2024 Direct
Turnstone Biologics Corp. Director, 10%+ Owner Stock Option (Right to Buy) 12.8K Jun 3, 2024 Direct
Turnstone Biologics Corp. Director, 10%+ Owner Series B-1 Preferred Stock 0 Jul 20, 2023 Indirect
Turnstone Biologics Corp. Director, 10%+ Owner Series B-2 Preferred Stock 0 Jul 20, 2023 Indirect
Turnstone Biologics Corp. Director, 10%+ Owner Series C Preferred Stock 0 Jul 20, 2023 Indirect
Turnstone Biologics Corp. Director, 10%+ Owner Series D Preferred Stock 0 Jul 20, 2023 Indirect

Insider Reports Filed by Rishi Gupta

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TSBX Turnstone Biologics Corp. Jun 3, 2024 1 $0 4 Jul 2, 2024 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. May 16, 2024 2 -$22.9M 4 May 20, 2024 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4/A Feb 20, 2024 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 Director, 10%+ Owner
TSBX Turnstone Biologics Corp. Oct 16, 2023 1 $0 4 Oct 17, 2023 Director, 10%+ Owner
TSBX Turnstone Biologics Corp. Jul 20, 2023 6 $5M 4 Jul 24, 2023 Director, 10%+ Owner
TSBX Turnstone Biologics Corp. Jul 20, 2023 0 $0 3 Jul 20, 2023 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. May 17, 2023 2 $9.1K 4 May 19, 2023 Director, 10%+ Owner
VRNA Verona Pharma plc May 11, 2023 4 -$9.94M 4 May 15, 2023 Director
VRNA Verona Pharma plc Apr 28, 2023 1 $0 4 Apr 28, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 1 $0 4 Apr 6, 2023 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 2 $0 4 Feb 27, 2023 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Feb 27, 2023 Director, 10%+ Owner
VRNA Verona Pharma plc Dec 22, 2022 5 -$136M 4 Dec 27, 2022 Director
VRNA Verona Pharma plc Apr 28, 2022 1 $0 4 Apr 29, 2022 Director
VRNA Verona Pharma plc Aug 9, 2021 1 $0 4 Aug 10, 2021 Director